Related Experiment Video

Updated: Mar 7, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K

Salinomycin Abolished STAT3 and STAT1 Interactions and Reduced Telomerase Activity in Colorectal Cancer Cells

Seyung S Chung1,2,3, Debbie Adekoya4,2, Ikechukwu Enenmoh4,2

  • 1Department of Internal Medicine, Division of Cancer Research and Training, Los Angeles, CA, U.S.A. seyungchung@cdrewu.edu jayvadgama@cdrewu.edu jvadgama@ucla.edu.

Anticancer Research
|February 10, 2017
PubMed
Abstract

Insights

Salinomycin, a cancer stem cell inhibitor, disrupts STAT3-STAT1 interactions and reduces colorectal cancer stemness. This finding suggests salinomycin as a potential targeted therapy for metastatic colorectal cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Colorectal cancer (CRC) is a leading cause of cancer mortality, often due to liver metastasis and recurrence.
  • Metastatic CRC presents a significant therapeutic challenge, driving the search for novel drug targets.
  • Cancer stem cells (CSCs) are implicated in CRC progression and therapeutic resistance.

Purpose of the Study:

  • To investigate the molecular mechanisms of salinomycin, a known CSC inhibitor, in colorectal cancer.
  • To explore salinomycin's potential as a targeted therapy for metastatic colorectal cancer.
  • To elucidate how salinomycin affects key signaling pathways and CSC properties in CRC.

Main Methods:

  • Co-immunoprecipitation assays to analyze STAT3-STAT1 protein interactions.
  • Telomerase activity measurement using PCR and ELISA.
  • Apoptosis and cell stress array analysis to identify salinomycin-responsive proteins.

Main Results:

  • Salinomycin abolished Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-α) induced STAT3-STAT1 interactions.
  • Salinomycin significantly reduced the cancer stem cell phenotype in colorectal cancer cells.
  • A decrease in telomerase activity was observed in colorectal cancer cells treated with salinomycin.

Conclusions:

  • Salinomycin inhibits colorectal cancer stemness through a novel mechanism involving the disruption of STAT3-STAT1 interactions.
  • These findings highlight salinomycin's potential as a targeted therapeutic agent for metastatic colorectal cancer.
  • Targeting cancer stemness pathways with agents like salinomycin may offer a new strategy against refractory CRC.
Keywords:
Cancer stem cellsMST-312STAT1STAT3salinomycintelomerase

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.5K
Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

9.0K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.5K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K